Joel H B.

Joel H B. has a strong background in sales, marketing, and strategy, with a focus on the medical device industry.

Joel H is currently serving as the Vice President of Sales, Marketing, and Strategy at Bioventus, where they lead the Advanced Rehabilitation Business Unit and is responsible for driving sales execution, marketing strategy, and post-sale customer support. Joel H was also awarded the Division Vice President of the Year in 2022.

Before joining Bioventus, Joel worked at Bioness Inc. as the Vice President of Marketing and Strategy from 2019 to 2021. During their tenure, they operated in a multi-national corporation that specialized in neuromodulation devices, robotic systems, and therapy programs for patients with chronic pain and nervous system disorders.

Prior to Bioness Inc., Joel held a position at Abbott as Director of Neuromodulation for Chronic Pain. In this role, they led the America's Product Marketing team, successfully executing on $600M+ in annual revenue for chronic pain and movement disorder treatments.

Earlier in their career, Joel worked at Bioness Inc. as the Senior Director of Marketing from 2006 to 2017. Joel H led the global marketing team, managed product portfolios, and collaborated with executive leaders to develop marketing strategies and budgets. Additionally, they served as a Business Development Manager and Product Manager, driving significant revenue growth through sales and marketing initiatives.

Joel began their career as a Research Associate II at Prismedical Corporation in 2003.

Overall, Joel H B. has a depth of experience in sales, marketing, and strategy within the medical device industry, specifically in the areas of neuromodulation, chronic pain, and rehabilitation therapies.

Joel H B. obtained a Bachelor of Science (B.S.) degree in Biomedical Sciences, Biology and Chemistry from Marquette University in 2003. Later, they pursued a Master of Business Administration (MBA) degree from the Lam Family College of Business at San Francisco State University, which they completed in 2007.